Literature DB >> 12070349

In vivo properties of an anti-GnRH Spiegelmer: an example of an oligonucleotide-based therapeutic substance class.

Britta Wlotzka1, Susanne Leva, Bernd Eschgfäller, Jens Burmeister, Frank Kleinjung, Christine Kaduk, Peter Muhn, Holger Hess-Stumpp, Sven Klussmann.   

Abstract

Spiegelmers are high-affinity l-enantiomeric oligonucleotide ligands that display high resistance to enzymatic degradation compared with d-oligonucleotides. The target binding properties of Spiegelmers can be designed by an in vitro-selection process starting from a random pool of oligonucleotides. Applying this method, a Spiegelmer with high affinity (K(D) = 20 nM) for the peptide hormone, gonadotropin-releasing hormone (GnRH) was isolated. The Spiegelmer acts as an antagonist to GnRH in Chinese hamster ovary cells stably expressing the human GnRH receptor, and its activity is unchanged by linking to 40-kDa polyethylene glycol. In a castrated rat model the Spiegelmer further demonstrated strong GnRH antagonist activity, which is more pronounced and persists longer with the polyethylene glycol-linked derivative. Furthermore, in rabbits the anti-GnRH Spiegelmer was shown to have a very low, possibly negligible immunogenic potential. These studies suggest that Spiegelmers could be of substantial interest in the development of new pharmaceutical approaches against GnRH and other targets.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12070349      PMCID: PMC124395          DOI: 10.1073/pnas.132067399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides.

Authors:  A A Levin
Journal:  Biochim Biophys Acta       Date:  1999-12-10

Review 2.  Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs.

Authors:  K R Reddy
Journal:  Ann Pharmacother       Date:  2000 Jul-Aug       Impact factor: 3.154

3.  Anti-L-selectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo.

Authors:  S R Watson; Y F Chang; D O'Connell; L Weigand; S Ringquist; D H Parma
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2000-04

4.  Gonadotropin-releasing hormone receptor initiates multiple signaling pathways by exclusively coupling to G(q/11) proteins.

Authors:  R Grosse; A Schmid; T Schöneberg; A Herrlich; P Muhn; G Schultz; T Gudermann
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

Review 5.  Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis.

Authors:  A V Schally
Journal:  Peptides       Date:  1999       Impact factor: 3.750

6.  PCR product with strands of unequal length.

Authors:  K P Williams; D P Bartel
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

Review 7.  The LHRH antagonist cetrorelix: a review.

Authors:  T Reissmann; A V Schally; P Bouchard; H Riethmiiller; J Engel
Journal:  Hum Reprod Update       Date:  2000 Jul-Aug       Impact factor: 15.610

8.  GnRH binding RNA and DNA Spiegelmers: a novel approach toward GnRH antagonism.

Authors:  Susanne Leva; Andrea Lichte; Jens Burmeister; Peter Muhn; Birgit Jahnke; Dirk Fesser; Jeannette Erfurth; Petra Burgstaller; Sven Klussmann
Journal:  Chem Biol       Date:  2002-03

Review 9.  Immunogenicity of biopharmaceuticals in laboratory animals.

Authors:  D Wierda; H W Smith; C M Zwickl
Journal:  Toxicology       Date:  2001-02-02       Impact factor: 4.221

10.  Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer.

Authors:  M S Simms; D P Scholfield; E Jacobs; D Michaeli; P Broome; J E Humphreys; M C Bishop
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

View more
  46 in total

1.  Inhibition of stimulated meningeal blood flow by a calcitonin gene-related peptide binding mirror-image RNA oligonucleotide.

Authors:  Thomas Denekas; Markus Tröltzsch; Axel Vater; Sven Klussmann; Karl Messlinger
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

2.  Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX.

Authors:  Axel Vater; Florian Jarosch; Klaus Buchner; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

3.  Bottom-up Assembly of RNA Arrays and Superstructures as Potential Parts in Nanotechnology.

Authors:  Dan Shu; Wulf-Dieter Moll; Zhaoxiang Deng; Chengde Mao; Peixuan Guo
Journal:  Nano Lett       Date:  2004-09       Impact factor: 11.189

4.  Expanding the concept of chemically programmable antibodies to RNA aptamers: chemically programmed biotherapeutics.

Authors:  Ulrich Wuellner; Julia I Gavrilyuk; Carlos F Barbas
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-09       Impact factor: 15.336

5.  In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals.

Authors:  Raphaël Boisgard; Bertrand Kuhnast; Stefan Vonhoff; Chéraz Younes; Françoise Hinnen; Jean-Marc Verbavatz; Bernard Rousseau; Jens Peter Fürste; Britta Wlotzka; Frédéric Dollé; Sven Klussmann; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-22       Impact factor: 9.236

6.  A DNA Spiegelmer to staphylococcal enterotoxin B.

Authors:  Werner G Purschke; Falko Radtke; Frank Kleinjung; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

7.  In vitro antibacterial effects of antilipopolysaccharide DNA aptamer-C1qrs complexes.

Authors:  J G Bruno; M P Carrillo; T Phillips
Journal:  Folia Microbiol (Praha)       Date:  2008-08-31       Impact factor: 2.099

Review 8.  In vitro selection using modified or unnatural nucleotides.

Authors:  Scott M Knudsen; Michael P Robertson; Andrew D Ellington
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2002-02

9.  Strategies for the discovery of therapeutic aptamers.

Authors:  Xianbin Yang; Na Li; David G Gorenstein
Journal:  Expert Opin Drug Discov       Date:  2011-01       Impact factor: 6.098

10.  Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer.

Authors:  Steffen Helmling; Christian Maasch; Dirk Eulberg; Klaus Buchner; Werner Schröder; Christian Lange; Stefan Vonhoff; Britta Wlotzka; Matthias H Tschöp; Stefan Rosewicz; Sven Klussmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.